The table below shows Fulgent Genetics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$322.67M
$283.47M
$289.21M
$618.97M
$992.58M
$421.71M
Cost of revenue
$191.80M
$176.25M
$184.76M
$252.07M
$215.53M
$89.81M
Gross profit
$130.88M
$107.22M
$104.46M
$366.90M
$777.05M
$331.90M
R&D
$53.91M
$48.82M
$41.44M
$28.91M
$24.22M
$11.58M
FLGT annual revenue (10-K history)
Fulgent Genetics, Inc. reported annual revenue of $322.67M for fiscal year 2025. That is up 13.8% from $283.47M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $18.28M (FY 2016) to $322.67M. Figures come from the company's audited annual reports as filed with the SEC.